A Double-Blind Study to Evaluate the Effects of Omeprazole and an H2 Antagonist in the Treatment of Barrett’s Esophagus.

Study identifier:MK-764A-016

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Double-Blind Study to Evaluate the Effects of Omeprazole and an H2 Antagonist in the Treatment of Barrett’s Esophagus.

Medical condition

Acid Reflux

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria